Skip to main content

Table 3 PharMetrics Database: Lung NET Incidence Rate, Cases per Million Person-Yearsa

From: Incidence and prevalence of neuroendocrine tumors of the lung: analysis of a US commercial insurance claims database

 

No. Of Cases Per Million Person-Years (Numerator/Denominator)

2011

2012

2013

2014

Gender

Age

            

 Female

18–24

2.5

(2

/809,900)

1.2

(1

/803,203)

0.0

(0

/844,220)

1.5

(1

/670,429)

25–34

5.5

(5

/915,829)

4.7

(4

/846,136)

3.5

(3

/851,694)

1.5

(1

/659,964)

35–44

2.2

(3

/1,387,525)

7.0

(9

/1,280,702)

12.8

(16

/1,249,676)

10.3

(10

/972,515)

45–54

10.0

(19

/1,902,036)

18.9

(33

/1,747,518)

18.9

(32

/1,688,747)

19.5

(25

/1,282,436)

55–64

37.6

(68

/1,809,406)

47.4

(81

/1,708,362)

55.4

(94

/1,697,399)

51.9

(67

/1,290,342)

All Female

14.2

(97

/6,824,696)

20.0

(128

/6,385,921)

22.9

(145

/6,331,736)

21.3

(104

/4,875,686)

 Male

18–24

1.2

(1

/828,261)

3.6

(3

/823,432)

2.3

(2

/875,326)

1.4

(1

/698,342)

25–34

2.4

(2

/839,247)

1.2

(1

/800,680)

0.0

(0

/818,984)

1.5

(1

/662,957)

35–44

5.5

(7

/1,266,850)

5.1

(6

/1,185,774)

3.4

(4

/1,164,816)

6.4

(6

/935,200)

45–54

10.5

(18

/1,713,588)

11.9

(19

/1,599,135)

12.8

(20

/1,556,840)

8.2

(10

/1,218,043)

55–64

28.7

(47

/1,637,294)

20.6

(32

/1,552,538)

23.2

(36

/1,551,338)

26.3

(32

/1,216,691)

All Male

11.9

(75

/6,285,240)

10.2

(61

/5,961,559)

10.4

(62

/5,967,304)

10.6

(50

/4,731,233)

 All Gender

18–24

1.8

(3

/1,638,161)

2.5

(4

/1,626,635)

1.2

(2

/1,719,546)

1.5

(2

/1,368,771)

25–34

4.0

(7

/1,755,076)

3.0

(5

/1,646,816)

1.8

(3

/1,670,678)

1.5

(2

/1,322,921)

35–44

3.8

(10

/2,654,375)

6.1

(15

/2,466,476)

8.3

(20

/2,414,492)

8.4

(16

/1,907,715)

45–54

10.2

(37

/3,615,624)

15.5

(52

/3,346,653)

16.0

(52

/3,245,587)

14.0

(35

/2,500,479)

55–64

33.4

(115

/3,446,700)

34.7

(113

/3,260,900)

40.0

(130

/3,248,737)

39.5

(99

/2,507,033)

All Patients

13.1

(172

/13,109,936)

15.3

(189

/12,347,480)

16.8

(207

/12,299,040)

16.0

(154

/9,606,919)

 

Adjusted Rate (No. Of Cases Per Million Person-Years)b

All Femalec

12.8

18.0

20.6

19.3

All Maled

10.6

9.3

9.3

9.6

All Patientse

11.7

13.8

15.2

14.6

  1. a Cases (adults with ≥1 inpatient or ≥ 2 outpatient claims for lung NET in listed year and continuous enrollment in year listed and two years prior) ÷ number of members with continuous enrollment in same period
  2. bAPC (95% CI; P value): female 14.7% (−12.9–51.2; 0.165); male −2.9% (−13.8–9.4; 0.395); all patients 7.8% (−5.7–23.4; 0.137)
  3. cAdjusted based on distribution of age among male from both databases in 2014
  4. dAdjusted based on distribution of age among female from both databases in 2014
  5. eAdjusted based on combined distribution of age among male from both databases in 2014
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us